Hippo Holdings Reports 2025 Profitability, Details Executive Compensation, and Board Changes Ahead of Annual Meeting
HIPO sits 45% above its 52-week low of $19.92 on light trading volume (0.3× avg).
Summary
Hippo Holdings Inc. filed its definitive proxy statement, revealing a return to net profitability in 2025, significant executive compensation details including a $2 million cash award to a transitioning executive, and substantial potential share dilution from equity plans.
Key Events · Corporate Governance and Compliance · HIPO
-
Annual Shareholder Meeting Scheduled
The company will hold its 2026 Annual Meeting of Stockholders virtually on Tuesday, June 2, 2026, to vote on director elections, auditor ratification, and advisory votes on executive compensation and its frequency.
-
Achieved Net Profitability in 2025
Hippo Holdings reported a net income of $58 million for fiscal year 2025, a significant improvement from a $41 million net loss in 2024. Gross written premium increased 24% to $1.1 billion, and net written premium grew 13% to $422 million.
-
Executive Compensation and Board Changes Detailed
Executive compensation for 2025 included increased target cash incentives for NEOs and the CEO, a $75,000 bonus for the CEO, and two $1,000,000 cash awards to Stewart Ellis (former CFO, now EVP & Chief Strategy Officer) for his transition. Eric Feder resigned from the Board, and Stewart Ellis was appointed as a non-independent Class I director effective June 3, 2026.
-
Significant Potential Share Dilution
The company has 6,572,794 shares remaining available for future issuance under its equity compensation plans, representing approximately 25.25% of the 26,031,227 common shares outstanding as of April 1, 2026.
Analysis · HIPO · Finance
This definitive proxy statement reveals Hippo Holdings' significant financial turnaround in 2025, achieving net income profitability for the first time with $58 million in net income and strong premium growth. This positive operational performance is a critical development for the company. However, the filing also highlights substantial potential dilution from equity compensation plans, with over 25% of current outstanding shares available for future issuance, which could weigh on shareholder value. Additionally, notable related-party transactions totaling several million dollars and a significant $2 million cash award to a transitioning executive warrant investor attention. The upcoming annual meeting will address routine governance matters, but the underlying financial and capital structure details are highly material.
At the time of this filing, HIPO was trading at $28.81 on NYSE in the Finance sector, with a market capitalization of approximately $748.2M. The 52-week trading range was $19.92 to $38.98. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.